Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing surgery-related mortality and morbidity
Editorial Group: Cochrane Anaesthesia Group
Published Online: 6 JUL 2011
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Zou Z, Yuan HB, Chen XY, Liu GJ, Shi XY. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing surgery-related mortality and morbidity (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 7. Art. No.: CD009210. DOI: 10.1002/14651858.CD009210.
- Publication Status: New
- Published Online: 6 JUL 2011
This is the protocol for a review and there is no abstract. The objectives are as follows:
The objective of this review is to systematically assess the benefits and harms of administration (prophylaxis or treatment or both) of Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type I receptors blockers (ARBs) in the short-term perioperative period for the prevention of surgery related mortality and morbidity.